Wave Life Sciences, a clinical-stage biotech in Cambridge, MA, uses GenAI and KNIME to automate biomedical research, leveraging LLMs, vector stores, and PubMed retrieval to enhance drug discovery and support clinical trials in Huntington’s, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency.